IPP Bureau
IOL Life Sciences incorporated as a subsidiary of IOL Chemicals and Pharmaceuticals
By IPP Bureau - June 22, 2022
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
Merck presents positive results from phase 1/2 study evaluating V116
By IPP Bureau - June 22, 2022
V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019
Merck appoints Chirfi Guindo as CMO for Merck Human Health
By IPP Bureau - June 22, 2022
Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.
Briefs: Marksans Pharma and Alkem
By IPP Bureau - June 22, 2022
The US FDA had conducted an inspection of Alkem Laboratories Limited's manufacturing facility located at St. Louis, USA.
Agilent Laboratory achieves Green Lab certification
By IPP Bureau - June 22, 2022
This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.
AstraZeneca and Merck announces results from phase 3 PROpel trial of Lynparza
By IPP Bureau - June 22, 2022
LYNPARZA is approved in the U.S. for patients with HRR gene-mutated mCRPC (BRCA-mutated and other HRR gene mutations)
MedC Biopharma partners with A2W Pharma to develop cannabinoid therapeutics
By IPP Bureau - June 22, 2022
Bringing next-gen cannabinoid therapeutics to cancer patients
Atik Cameras launches ChemiMOS for long exposure imaging
By IPP Bureau - June 22, 2022
Atik Cameras launches ChemiMOS; A 9MP CMOS camera for scientific applications
Sadhana Nitro Chem commences production of its 1st para aminophenol plant
By IPP Bureau - June 22, 2022
The company is now introducing the product into the India pharmaceutical market.
Iktos and Zealand Pharma to develop AI technology for peptide drug design
By IPP Bureau - June 22, 2022
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Cortexyme announces preclinical data demonstrating efficacy of COR803 for Covid infections
By IPP Bureau - June 22, 2022
COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
Apollo Hospitals becomes first in the APAC to bag three HIMSS Stage 6 certifications
By IPP Bureau - June 21, 2022
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
Indira IVF inaugurates new centre in Delhi Patel Nagar
By IPP Bureau - June 21, 2022
Indira IVF has established technological supremacy as the key differentiator, delivering industry leading success rate
Cadila Pharma launches formulation development lab
By IPP Bureau - June 21, 2022
The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab
Medix Biochemica acquires Bioresource Technology
By IPP Bureau - June 21, 2022
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
